cellular
• excessive DNA lesions in late passage MEFs
|
• reduced mitochondrial network filament length in late passage MEFs
|
• in late passage MEFs
|
• fewer cells actively dividing amongst synchronized MEFs in vitro
|
• double population doubling time of MEFs in vitro
|
• of MEFs in vitro
|
• reduced maximal respiration and oxygen consumption rates in late passage MEFs after etomoxir treatment
• normal basal and maximal respiration and oxygen consumption rates in early and late passage MEFs, either unchallenged or with exogenous palmitate after depletion of endogenous fatty acids
|
mortality/aging
• post-weaning population from het x het cross only 9% homozygous mutant
• normal Mendelian ratio in embryos
|
growth/size/body
• in late-stage embryos
|
embryo
• in late-stage embryos
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Friedreich ataxia | DOID:12705 | J:299300 |